$PMN
ProMIS Neurosciences Inc

2022 Q3 Form 10-Q Financial Statement

#000110465922089668 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $13.65K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.484M $1.635M $2.495M
YoY Change 73.98% 421.7% 539.85%
% of Gross Profit
Research & Development $4.571M $3.230M $2.606M
YoY Change 283.16% 328.16% 1271.58%
% of Gross Profit
Depreciation & Amortization $1.883K $2.108K $3.930K
YoY Change -87.75% -80.39% -60.7%
% of Gross Profit
Operating Expenses $6.054M $4.865M $5.101M
YoY Change 195.96% 340.07% 779.55%
Operating Profit -$6.054M -$4.865M -$3.939M
YoY Change 192.35% 340.07%
Interest Expense $97.26K $134.3K $2.008M
YoY Change -90.98% 0.45% -128.61%
% of Operating Profit
Other Income/Expense, Net $97.26K $2.120M $1.844M
YoY Change -88.69% 140.9%
Pretax Income -$5.957M -$2.745M -$3.079M
YoY Change 519.23% 823.17% -59.48%
Income Tax
% Of Pretax Income
Net Earnings -$6.000M -$2.700M -$3.079M
YoY Change 523.71% 1097.11% -59.48%
Net Earnings / Revenue -22559.63%
Basic Earnings Per Share -$0.85 -$0.38 -$0.29
Diluted Earnings Per Share -$0.85 -$0.38 -$427.9K
COMMON SHARES
Basic Shares Outstanding 7.196M 7.196M 7.196M
Diluted Shares Outstanding 7.196M 7.196M 7.196M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.951M $8.936M $17.22M
YoY Change -85.12% 28.44% 95.01%
Cash & Equivalents $3.921M $8.904M $17.18M
Short-Term Investments $30.54K $32.69K $42.08K
Other Short-Term Assets $1.408M $1.225M $651.6K
YoY Change -40.44% 78.28% 225.8%
Inventory
Prepaid Expenses
Receivables $125.9K
Other Receivables $0.00
Total Short-Term Assets $5.359M $10.16M $18.00M
YoY Change -81.6% 31.75% 94.35%
LONG-TERM ASSETS
Property, Plant & Equipment $788.00 $2.776K $6.260K
YoY Change -98.69% -96.17% -93.04%
Goodwill
YoY Change
Intangibles $21.73K $24.56K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $22.52K $27.33K $39.54K
YoY Change -76.75% -75.31% -69.58%
TOTAL ASSETS
Total Short-Term Assets $5.359M $10.16M $18.00M
Total Long-Term Assets $22.52K $27.33K $39.54K
Total Assets $5.382M $10.19M $18.04M
YoY Change -81.58% 30.23% 92.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.795M $888.0K $805.0K
YoY Change 210.11% 206.97% 159.66%
Accrued Expenses $1.304M $986.0K $930.7K
YoY Change 281.29% 270.69% 564.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.099M $1.874M $1.736M
YoY Change 41.35% 60.94% -22.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $5.057M
YoY Change -100.0% -100.0% 12.37%
Other Long-Term Liabilities $1.553M $1.605M $6.576M
YoY Change -87.65% -85.26% -42.01%
Total Long-Term Liabilities $1.553M $1.605M $11.63M
YoY Change -91.08% -89.62% -26.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.099M $1.874M $1.736M
Total Long-Term Liabilities $1.553M $1.605M $11.63M
Total Liabilities $4.652M $3.479M $13.37M
YoY Change -76.27% -79.07% -26.02%
SHAREHOLDERS EQUITY
Retained Earnings -$73.00M -$67.00M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $729.8K $6.710M $3.738M
YoY Change
Total Liabilities & Shareholders Equity $5.382M $10.19M $18.04M
YoY Change -81.58% 30.23% 92.08%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.000M -$2.700M -$3.079M
YoY Change 523.71% 1097.11% -59.48%
Depreciation, Depletion And Amortization $1.883K $2.108K $3.930K
YoY Change -87.75% -80.39% -60.7%
Cash From Operating Activities -$4.636M -$4.555M -$4.264M
YoY Change 41.88% 143.53% 335.14%
INVESTING ACTIVITIES
Capital Expenditures $30.00 -$37.00 -$2.610K
YoY Change -102.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $30.00 -$37.00 -$2.610K
YoY Change -102.0% -101.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -4.636M -4.555M -4.264M
Cash From Investing Activities 30.00 -37.00 -2.610K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -4.636M -4.555M -4.267M
YoY Change -123.66% 143.16% -154.99%
FREE CASH FLOW
Cash From Operating Activities -$4.636M -$4.555M -$4.264M
Capital Expenditures $30.00 -$37.00 -$2.610K
Free Cash Flow -$4.636M -$4.555M -$4.262M
YoY Change 41.94% 143.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16943905
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
32687
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
33248
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1225201
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
737316
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10161664
CY2021Q4 us-gaap Assets Current
AssetsCurrent
17714469
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2776
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4671
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24557
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7195529
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8903776
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0647155
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 200, 1920 Yonge Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Toronto
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27614
CY2022Q2 us-gaap Assets
Assets
10188997
CY2021Q4 us-gaap Assets
Assets
17746754
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
888015
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
408981
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
986033
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M4S 3E2
dei City Area Code
CityAreaCode
416
dei Local Phone Number
LocalPhoneNumber
847-6898
dei Security12b Title
Security12bTitle
Common Shares, no par value per share
dei Trading Symbol
TradingSymbol
PMN
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
520093
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1874048
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
929074
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
3906057
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5379878
CY2022Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
1605020
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
1871687
CY2022Q2 us-gaap Liabilities
Liabilities
3479068
CY2021Q4 us-gaap Liabilities
Liabilities
12086696
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.30
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195529
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5099172
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195529
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000935
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195529
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000935
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.30
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5183
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5183
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5183
CY2019Q3 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P1Y
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
70000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
dei Entity Central Index Key
EntityCentralIndexKey
0001374339
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
70000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41429
dei Entity Registrant Name
EntityRegistrantName
PROMIS NEUROSCIENCES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
70000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73879455
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68039178
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-138442
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-187919
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67031084
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62191201
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6709929
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5660058
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10188997
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17746754
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3229584
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
754302
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5132416
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
973893
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1635065
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
351114
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3670751
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
699492
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
4864649
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1105416
us-gaap Operating Expenses
OperatingExpenses
8803167
us-gaap Operating Expenses
OperatingExpenses
1673385
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4864649
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1105416
us-gaap Operating Income Loss
OperatingIncomeLoss
-8803167
us-gaap Operating Income Loss
OperatingIncomeLoss
-1673385
CY2022Q2 us-gaap Interest Expense
InterestExpense
134291
CY2021Q2 us-gaap Interest Expense
InterestExpense
133686
us-gaap Interest Expense
InterestExpense
282064
us-gaap Interest Expense
InterestExpense
135405
CY2022Q2 pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
930193
CY2021Q2 pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
1013880
pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
2910865
pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
-4523685
CY2022Q2 pmn Gains Losses On Extinguishment Of Debt And Derivative Liability
GainsLossesOnExtinguishmentOfDebtAndDerivativeLiability
1307421
pmn Gains Losses On Extinguishment Of Debt And Derivative Liability
GainsLossesOnExtinguishmentOfDebtAndDerivativeLiability
1307421
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16288
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-321
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27062
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2379
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2119611
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
879873
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3963284
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4661469
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2745038
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-225543
us-gaap Net Income Loss
NetIncomeLoss
-4839883
us-gaap Net Income Loss
NetIncomeLoss
-6334854
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1636
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-91842
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
49477
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-145217
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2743402
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-317385
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4790406
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6480071
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.30
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5099172
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000935
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-796658
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
207851
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-145217
us-gaap Net Income Loss
NetIncomeLoss
-6334854
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-7068878
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5660058
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
240277
pmn Stock Issued During Period Value Conversion Of Convertible Debt And Derivative Liability
StockIssuedDuringPeriodValueConversionOfConvertibleDebtAndDerivativeLiability
5600000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
49477
us-gaap Net Income Loss
NetIncomeLoss
-4839883
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6709929
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-6880667
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
129174
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-91842
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-225543
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-7068878
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3737919
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
115412
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5600000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1636
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2745038
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6709929
us-gaap Profit Loss
ProfitLoss
-4839883
us-gaap Profit Loss
ProfitLoss
-6334854
us-gaap Share Based Compensation
ShareBasedCompensation
240277
us-gaap Share Based Compensation
ShareBasedCompensation
207851
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-251033
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
96672
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2643123
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-4523685
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-267742
us-gaap Depreciation
Depreciation
3887
us-gaap Depreciation
Depreciation
21477
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
250060
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
97404
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2622
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2637
pmn Gains Losses On Extinguishment Of Debt And Derivative Liability
GainsLossesOnExtinguishmentOfDebtAndDerivativeLiability
1307421
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
506194
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
463128
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
491640
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-212309
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
480287
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
163704
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-138232
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7844557
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2228437
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2048
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2372
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2048
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2372
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6882531
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6882531
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-193524
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110758
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8040129
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4767224
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16943905
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
806887
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8903776
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5574111
pmn Conversion Of Convertible Debt And Derivative Liability To Series1 Convertible Preferred Shares
ConversionOfConvertibleDebtAndDerivativeLiabilityToSeries1ConvertiblePreferredShares
5600000
us-gaap Interest Paid Net
InterestPaidNet
87069
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2700000
us-gaap Net Income Loss
NetIncomeLoss
-4800000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67000000.0
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1234
CY2022Q2 us-gaap Share Price
SharePrice
6.35
CY2021Q2 us-gaap Share Price
SharePrice
14.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.988
CY2022Q2 pmn Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
60
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 36pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The preparation of financial statements in conformity with GAAP requires management to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made in the accompanying unaudited condensed consolidated financial statements include, but are not limited to, the accrual for research and development expenses, the valuation of share-based compensation, and the valuation of warrant liabilities and embedded derivative liabilities. Actual results could differ from those estimates, and such differences could be material to the unaudited condensed consolidated financial statements.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q2 pmn Prepaid Consultants Current
PrepaidConsultantsCurrent
56910
CY2021Q4 pmn Prepaid Consultants Current
PrepaidConsultantsCurrent
69915
CY2022Q2 pmn Prepaid Upfront Research Payments Current
PrepaidUpfrontResearchPaymentsCurrent
845387
CY2021Q4 pmn Prepaid Upfront Research Payments Current
PrepaidUpfrontResearchPaymentsCurrent
554878
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
56421
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
48690
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
14725
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
32853
CY2022Q2 pmn Prepaid Dues And Subscriptions Current
PrepaidDuesAndSubscriptionsCurrent
25791
CY2022Q2 pmn Prepaid License Fee Current
PrepaidLicenseFeeCurrent
33944
CY2021Q4 pmn Prepaid License Fee Current
PrepaidLicenseFeeCurrent
19754
CY2022Q2 us-gaap Deposit Assets
DepositAssets
13605
CY2021Q4 us-gaap Deposit Assets
DepositAssets
6839
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
176904
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1514
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4387
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1225201
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
737316
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2591
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5183
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84668
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84060
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81892
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79389
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2776
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4671
CY2022Q2 us-gaap Depreciation
Depreciation
2108
CY2021Q2 us-gaap Depreciation
Depreciation
10750
us-gaap Depreciation
Depreciation
3887
us-gaap Depreciation
Depreciation
21477
CY2012Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
100000
CY2012Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
77683
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
79015
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53126
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51401
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24557
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27614
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1306
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1320
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2622
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2637
CY2022Q2 pmn Accrued Legal Fees Current
AccruedLegalFeesCurrent
-100164
CY2021Q4 pmn Accrued Legal Fees Current
AccruedLegalFeesCurrent
-171777
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
73662
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
123026
CY2022Q2 pmn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
-569335
CY2021Q4 pmn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
-106845
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
54398
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
242872
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
64047
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
986033
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
520093
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2741058
CY2022Q2 pmn Common Stock Fair Value Per Share On Conversion Date
CommonStockFairValuePerShareOnConversionDate
0.08
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
70000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1560588
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1560588
CY2022Q2 us-gaap Convertible Preferred Stock Shares Reserved For Future Issuance
ConvertiblePreferredStockSharesReservedForFutureIssuance
1166667
CY2021Q4 pmn Convertible Debt Shares Reserved For Future Issuance
ConvertibleDebtSharesReservedForFutureIssuance
1166667
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
834691
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
738037
CY2022Q2 pmn Deferred Share Units Outstanding
DeferredShareUnitsOutstanding
1061
CY2021Q4 pmn Deferred Share Units Outstanding
DeferredShareUnitsOutstanding
1061
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
185144
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
281798
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3748151
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3748151
pmn Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2022Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
6.00
CY2022Q2 pmn Value Divided To Ascertain Shares Convertible
ValueDividedToAscertainSharesConvertible
0.10
CY2022Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.10
pmn Preferred Stock Convertible Conversion Price After Reverse Stock Split
PreferredStockConvertibleConversionPriceAfterReverseStockSplit
6.00
CY2022Q2 pmn Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
60
pmn Minimum Gross Proceeds From Sale Of Equity Securities
MinimumGrossProceedsFromSaleOfEquitySecurities
30000000
CY2021Q3 pmn Payments Of Warrants Issuance Costs
PaymentsOfWarrantsIssuanceCosts
444558
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1560588
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
738037
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.40
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2231293
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
151666
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
55013
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.59
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
834691
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.64
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
471532
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
629886
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
597539
pmn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
964305
pmn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
328148
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.900
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0259
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
16666
CY2022Q2 pmn Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Redeemable Per Unit
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesRedeemablePerUnit
1
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
116943
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
126264
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
240277
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
207851
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1387704
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3563007
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2769095
CY2016Q2 pmn Related Party Transaction Term Of Agreement
RelatedPartyTransactionTermOfAgreement
P3Y
CY2018Q1 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
892500
CY2018Q3 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
1130000
CY2019Q1 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
2130000
CY2019Q1 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P2Y
CY2019Q3 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
2630000
CY2021Q4 pmn Related Party Transaction Additional Grant Commitment
RelatedPartyTransactionAdditionalGrantCommitment
800000
CY2022Q1 pmn Related Party Transaction Additional Grant Commitment
RelatedPartyTransactionAdditionalGrantCommitment
3430000
us-gaap Related Party Costs
RelatedPartyCosts
255563
us-gaap Related Party Costs
RelatedPartyCosts
197634
CY2022Q2 pmn Collaborative Arrangement Accruals For Royalty Payments
CollaborativeArrangementAccrualsForRoyaltyPayments
0
CY2022Q1 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P3Y
us-gaap Short Term Lease Cost
ShortTermLeaseCost
20301
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5150
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9001
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4790406
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6480071
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000935
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.30

Files In Submission

Name View Source Status
0001104659-22-089668-index-headers.html Edgar Link pending
0001104659-22-089668-index.html Edgar Link pending
0001104659-22-089668.txt Edgar Link pending
0001104659-22-089668-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pmn-20220630.xsd Edgar Link pending
pmn-20220630x10q.htm Edgar Link pending
pmn-20220630xex31d1.htm Edgar Link pending
pmn-20220630xex31d2.htm Edgar Link pending
pmn-20220630xex32d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
pmn-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pmn-20220630_lab.xml Edgar Link unprocessable
pmn-20220630x10q_htm.xml Edgar Link completed
pmn-20220630_def.xml Edgar Link unprocessable
pmn-20220630_pre.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending